annb0t
Top 20
Haemonetics HAE has been gaining from business growth within Plasma, Hospital and Hemostasis Management. Its new launches also aid growth. The stock carries a Zacks Rank #1 (Strong Buy) currently.
Haemoneticsâ Plasma revenues grew 6% in the fourth quarter of fiscal 2024, driven primarily by disposable volume and software. The collections environment in the United States continued to be favorable, with disposables growing 4% in the quarter and 13% in fiscal 2024.
The company is gaining f...
>>> Read more: Haemonetics (HAE) Banks on Growing Plasma Arm, Innovation
Haemoneticsâ Plasma revenues grew 6% in the fourth quarter of fiscal 2024, driven primarily by disposable volume and software. The collections environment in the United States continued to be favorable, with disposables growing 4% in the quarter and 13% in fiscal 2024.
The company is gaining f...
>>> Read more: Haemonetics (HAE) Banks on Growing Plasma Arm, Innovation
